The present disclosure relates generally to medical devices and, more particularly, to sensors used for sensing physiological parameters of a patient.
This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present disclosure, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present disclosure. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
In the field of medicine, doctors often desire to monitor certain physiological characteristics of their patients. To allow such monitoring, various types of sensors and monitors may be employed by caregivers. For example, to measure certain characteristics, optical based sensors may be utilized that transmit electromagnetic radiation, such as light, through a patient's tissue and then photoelectrically detect the absorption and scattering of the transmitted or reflected light in such tissue. The physiological characteristics of interest may then be calculated based upon the amount of light absorbed and/or scattered or based upon changes in the amount of light absorbed and/or scattered. In such measurement approaches, the light passed through the tissue is typically selected to be of one or more wavelengths that may be absorbed and/or scattered by one or more constituents of the blood or tissue in an amount correlative to the amount of the constituents present in the blood or tissue.
One technique for monitoring certain physiological characteristics of a patient is commonly referred to as pulse oximetry, and the devices built based upon pulse oximetry techniques are commonly referred to as pulse oximeters. Pulse oximetry may be used to measure various blood flow characteristics, such as the blood-oxygen saturation of hemoglobin (SpO2) in arterial blood, the volume of individual blood pulsations supplying the tissue, and/or the rate of blood pulsations corresponding to each heartbeat of a patient. In fact, the “pulse” in pulse oximetry refers to the time varying amount of arterial blood in the tissue during each cardiac cycle.
Pulse oximeters typically utilize a non-invasive sensor that transmits light through a patient's tissue and that photoelectrically detects the absorption and/or scattering of the transmitted light in such tissue. One or more of the above physiological characteristics may then be calculated based upon the amount of light absorbed or scattered. As noted above, the light passed through the tissue is typically selected to be of one or more wavelengths that may be absorbed or scattered by the blood in an amount con'elative to the amount of the blood constituent present in the blood. The amount of light absorbed and/or scattered may then be used to estimate the amount of blood constituent in the tissue using various algorithms.
The light sources used in pulse oximeters, as well as other medical devices, may be designed to emit wavelengths that correspond to the physiological characteristics to be determined. For example, pulse oximeters may utilize light sources that emit in at least two spectral regions, one that emits in the red region (typically about 660 nm) and one in the near infrared region (typically about 900 nm). The absorbance ratios for these wavelengths can then be used to determine the oxygenation of a patient's blood. In another example, some pulse oximeters may replace the 660 nm emitter with an emitter designed to emit light in the far red region (typically about 730 nm), The 730 nm emitter may then be used in conjunction a 900 nm emitter to determine the oxygenation of a patient's blood. The use of a 730 nm emitter and a 900 nm emitter may provide greater accuracy when SpO2 is low (e.g., in the range below 75%).
The wavelengths emitted by the sensors can vary between sensors and can vary during operation of the medical device. For example, due to manufacturing variations, light sources, such as light emitting diodes (LEDs) or laser diodes, may emit slightly different wavelengths. Accordingly, calibration models may be included in pulse oximeters to account for these variations. However, the inclusion of calibration models can complicate manufacturing and introduce additional costs. In another example, changes in temperature can affect the wavelength emitted by the sensors. For example, the ambient temperature may vary and/or the temperature of the sensor itself may vary as the driving strength changes. These variations in a sensor's emitted wavelength may affect the accuracy of the determined physical characteristics.
Advantages of the disclosed techniques may become apparent upon reading the following detailed description and upon reference to the drawings in which:
One or more specific embodiments of the present techniques will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
The present disclosure relates to techniques for controlling the temperature of light sources within physiological sensors. The sensors may include a temperature control element designed to provide heating and/or cooling to the light sources. The light sources, in certain embodiments, may be light emitting diodes or laser diodes. The sensors also may include a temperature sensor designed to detect the temperature of the light sources. Based on the detected temperature, a controller can vary the amount of heating and/or cooling provided by the temperature control element to maintain the temperature of the light sources at a desired temperature or within a desired temperature range. In another embodiment, the detector may be sensitive to the wavelength of received light and may estimate temperature or temperature changes based on absolute wavelength, the absolute wavelength relative to a calibration, from a previously measured wavelength, or based on wavelength changes and a calibration. In these embodiments, the controller may vary the amount of heating and/or cooling provided by the temperature control element to compensate for the temperature change determined based on information from the detector.
The wavelengths of light emitted by the light sources can vary with temperature. Accordingly, in certain embodiments, the controller can be employed to maintain the temperature of the light sources at a temperature that enables the light sources to produce desired wavelengths of light. For example, the temperature control element may be employed to adjust the wavelength emitted the light sources to correspond to a calibration wavelength. In another example, the temperature control element may be employed to allow one light source to be employed to produce multiple wavelengths of light used to determine certain physiological parameters, such as total hemoglobin. Further, the temperature control element can be employed to provide temperature adjustments that compensate for changes in the ambient temperature and/or the operational temperature of the sensor. In these embodiments, the temperature control element may be employed to maintain a consistent temperature for the emitters, which can provide repeatability in the measurements taken using the emitters. Moreover, the temperature control element can be employed to warm the tissue beneath the sensor to promote increased blood flow and/or to cool the sensor, for example, to maintain the tissue beneath the sensor at a comfortable temperature.
According to certain embodiments, the temperature control element may include a thermoelectric element that is switchable between a cooling mode and a heating mode. The controller may vary the level of power provided to the thermoelectric element to adjust the amount of heating or cooling provided by the thermoelectric element. Further, the controller may govern one or more switches that can reverse the direction of current flow through the thermoelectric element to switch the thermoelectric element between the heating mode and the cooling mode. In other embodiments, the temperature control element may include a heating element, such as a resistive heater, that provides heating, while a thermoelectric cooler provides cooling. Moreover, in yet other embodiments, the temperature control element may be designed to provide only heating or only cooling.
With the foregoing considerations in mind,
The monitor 14 may include a display 20 configured to display information regarding the physiological parameters, information about the system, and/or alarm indications. For example, the display 20 may be configured to display computed physiological data such as an oxygen saturation percentage, a pulse rate, and/or a plethysmographic waveform. The monitor 14 also may include various input components 22, such as knobs, switches, keys and keypads, buttons, etc., to provide for operation and configuration of the monitor.
In certain embodiments, the monitor 14 may be coupled to a multi-parameter patient monitor 24 to provide additional functionality. For example, the monitor 14 may be connected to the multi-parameter patient monitor 24 via a cable 26 connected to a sensor input port or via a cable 28 connected to a digital communication port. In addition to the monitor 14, or alternatively, the multi-parameter patient monitor 24 may be configured to calculate physiological parameters and to provide a central display 30 for information from the monitor 14 and from other medical monitoring devices or systems. In some embodiments, the monitor 24 may be configured to display and/or determine some or all of the same physiological parameters as monitor 14. The monitor 24 also may include various input components 32, such as knobs, switches, keys and keypads, buttons, etc., to provide for operation and configuration of the monitor 24. Further, the monitor 14 and/or the multi-parameter patient monitor 24 may be connected to a network to enable the sharing of information with servers or other workstations.
The sensor 12 may be any sensor suitable for detection of any physiological parameter. According to certain embodiments, the sensor 12 may be configured for photoelectric detection of blood and tissue constituents. For example, the sensor 12 may be a pulse oximetry sensor, such as those available from Nellcor Puritan Bennett, L.L.C. The sensor 12 may include an emitter 34 for emitting light at certain wavelengths into a patient's tissue and a detector 36 for detecting the light after it is reflected and/or absorbed by the patient's tissue. The sensor 12 also may include a temperature control element 38 for controlling the temperature of light sources in the emitter 34, as discussed further below with respect to
As shown in
Turning to
Although two light sources are shown in
It should be understood that, as used herein, the term “light” may refer to one or more of ultrasound, radio, microwave, millimeter wave, infrared, visible, ultraviolet, gamma ray or X-ray electromagnetic radiation, and may also include any wavelength within the radio, microwave, infrared, visible, ultraviolet, or X-ray spectra, and that any suitable wavelength of light may be appropriate for use with the present disclosure. In operation, light enters the detector 36 after passing through the tissue of the patient 48. The detector 36 may convert the light at a given intensity, which may be directly related to the absorbance and/or reflectance of light in the tissue of the patient 48, into an electrical signal. That is, when more light at a certain wavelength is absorbed or reflected, less light of that wavelength is typically received from the tissue by the detector 36. For example, the detector 36 may include one or more photodiodes, or any other element capable of converting light into either a current or voltage. After converting the received light to an electrical signal, the detector 36 may send the signal to the monitor 14, where physiological characteristics may be calculated based at least in part on the absorption of light in the tissue of the patient 48.
The sensor 12 also includes the temperature control element 38 and the temperature sensor 40, which can be used to regulate the temperature of the emitter 34 and its light sources 44 and 46. The temperature sensor 40 may be any device suitable for measuring temperature, such as a thermistor or thermocouple, among others. The temperature sensor 40 may be located in close proximity to the emitter 34 or may be coupled to the emitter 34 in order to detect the temperature of the light sources 44 and 46. The temperature control element 38 may include one or more elements designed to provide heating and/or cooling. For example, the temperature control element 38 may be a thermoelectric element that is switchable between a cooling mode to provide cooling and a heating mode to provide heating. In another example, the temperature control element 38 may include a thermoelectric cooler that provides cooling and a resistive heater that provides heating. Further, in yet other embodiments, the temperature control element 38 may be designed to provide only heating or only cooling. The temperature control element 38 may be disposed in close proximity to the light sources 44 and 46 or may be coupled to the light sources 44 and 46 and/or the emitter 34 to provide heating and/or cooling to the light sources 44 and 46.
The temperature control element 38 and the temperature sensor 40 can be used in conjunction with one or more processors 50 of the monitor 14 to provide closed loop control of the temperature of the light sources 44 and 46. In particular, the temperature control element 38 may be used to maintain the temperature of light sources 44 and 46 at a target temperature set point or within a target temperature range. Because the wavelengths emitted by the light sources 44 and 46 can vary with temperature, the target temperature set point may be selected to correspond to a desired wavelength of light. For example, as discussed further below with respect to
The sensor 12 also includes the encoder 42, which contains information about the sensor 12, such as the sensor type (e.g., whether the sensor is intended for placement on a forehead, digit, or other body part) and the wavelengths of light emitted by the light sources 44 and 46. The sensor information may allow the monitor 14 to select appropriate algorithms and/or calibration coefficients for calculating the physiological characteristics of the patient 48. Further, the information may be used by the monitor 14 to determine a target temperature set point and/or target temperature range for the light sources 44 and 46. According to certain embodiments, the encoder 42 may include a memory on which one or more of the following information may be stored for communication to the monitor 14: the type of the sensor 12; the wavelengths of light emitted by the light sources 44 and 46; and the proper calibration coefficients and/or algorithms to be used for calculating the physiological characteristics of the patient 48.
Signals from the encoder 42 can be transmitted to a detector/decoder 52 in the monitor 14 where the data and signals can be decoded. The detector/decoder 52 may decode the signals from the encoder 42 and may provide the decoded information to the processor 50. According to certain embodiments, the decoded information may represent the type of the sensor 12 and the wavelengths of light emitted by the light sources 44 and 46. The processor 50 may then use the decoded information to determine the proper method for calculating the patient's physiological characteristics. For example, the processor may use the decoded information in conjunction with algorithms or look-up tables to identify the proper calibration coefficients and/or algorithms to be used for calculating the patient's physiological characteristics.
Signals from the detector 36 also may be transmitted to the monitor 14 where the signals can be used to calculate the patient's physiological characteristics. The monitor 14 generally includes the one or more processors 50 connected to an internal bus 54. The bus 54 is also connected to the input components 22 and the display 20, as well as a read-only memory (ROM) 56, a random access memory (RAM) 58, and a nonvolatile storage 60 (such as a magnetic or solid state hard drive or memory, optical disk, or any other suitable optical, magnetic, or solid-state computer readable media) that stores longer-term data.
A time processing unit (TPU) 62 may provide timing control signals to a light drive circuitry 64, which controls when the emitter 34 is illuminated and the multiplexed timing for the light sources 44 and 46. The TPU 62 also may control the gating-in of signals from detector 36 through a switching circuit 66. These signals may be sampled at the proper time, depending upon which light source 44 or 46 is illuminated. The received signal from the detector 36 may be passed through an amplifier 68, a low pass filter 70, and an analog-to-digital converter 72 for amplifying, filtering, and digitizing the electrical signals the from the sensor 12. The digital data may then be stored in a queued serial module (QSM) 74 for later downloading to the RAM 58 as the QSM 74 fills up. In certain embodiments, there may be multiple separate parallel paths having the amplifier 68, the filter 70, and the AID converter 72 for multiple light wavelengths or spectra received.
The processor 50 may use the digital data, as well as other signals from the detector 36 to calculate and/or determine physiological characteristics, such as oxygen saturation, pulse rate, and total hemoglobin, among others. For example, the processor 50 may use various encoded instructions, algorithms, and/or lookup tables that may be stored in the ROM 56, as well as in the nonvolatile storage 60, to calculate the physiological characteristics based at least in part upon the signals that correspond to the light received by the detector 36. According to certain embodiments, code encoding executable algorithms may be stored in the ROM 56 or the nonvolatile storage 60 and accessed and operated according to processor instructions. The calculated physiological characteristic may then be displayed on the display 20 for a caregiver to monitor or review. In certain embodiments, the processor 50 also may access and execute coded instructions for adjusting the temperature of the light sources 44 and 46 using the temperature control element 38. According to certain embodiments, one or more algorithms and/or lookup tables may be stored in the ROM 56 or the nonvolatile storage 60 and employed by the processor 50 to adjust the temperature of the light sources 44 and 46.
The monitor 14 further includes a power source 76 that may be used to transmit power to the components located in the monitor 14 and/or the sensor 12. In one embodiment, the power source 76 may be one or more batteries, such as a rechargeable battery. The battery may be user-removable or may be secured within the housing of the monitor 14. Use of a battery may, for example, allow the monitor 14 to be highly portable, thus allowing a user to carry and use the monitor 14 in a variety of situations and locations. Additionally, the power source 76 may include AC power, such as provided by an electrical outlet, and the power source 76 may be connected to the AC power via a power adapter through a power cord (not shown). This power adapter may also be used to directly recharge one or more batteries of the power source 76 and/or to power the monitor 14.
The power source 76 also may provide power to the temperature control element 38 within the sensor 12. According to certain embodiments, the power source 76 may include DC power that can be provided to the temperature control element 38, For example, the power source 76 may include an AC/DC converter that converts AC power provided by an electrical outlet to DC power. According to certain embodiments, the level of power provided to the temperature control element 38 may determine the amount of heating and/or cooling generated by the temperature control element 38. For example, in embodiments where the temperature control element 38 includes a thermoelectric element, the amount of cooling and/or heating provided may be proportional to the applied current. According to certain embodiments, the processor 50 may control the level of power provided to the temperature control element 38 from the power source 76. For example, the processor 50 may employ one or more algorithms and/or instructions stored in the ROM 56 or the nonvolatile storage 60 to determine the level of power that should be provided to the temperature control element 38. Further, in certain embodiments, the processor 50 may employ linear control or pulse width modulation (PWM) control to govern the level of power provided to the temperature control element 38. As discussed further below with respect to
The temperature control element 38 is located within the housing 80 in close proximity to the emitter 34 so that heat can be exchanged between the temperature control element 38 and the emitter 34. As discussed above with respect to
The temperature control element 38 may be disposed on the opposite side of the emitter 34 from the finger 78. Accordingly, when the temperature control element 38 is providing cooling, heat can be transferred from the emitter 34 to the temperature control element 38 and then released to the ambient air surrounding the sensor 12. In certain embodiments, a portion of the housing 80 may be omitted in the region adjacent to the temperature control element 38 to allow the temperature control element 38 to directly contact the ambient air. However, in other embodiments, at least a portion of the housing 80 that surrounds the temperature control element 38 may include a thermally conductive material that allows heat to be transferred from the temperature control element 38 through the housing to the ambient air.
As shown in
In the embodiment shown in
According to certain embodiments, the thermoelectric materials 90 and 92 may include semiconductor materials, such as semiconductor pellets of bismuth telluride or other suitable materials. The thermoelectric material 90 is an N-type thermoelectric material, while the thermoelectric material 92 is P-type thermoelectric material. The thermoelectric materials 90 and 92 may be doped by introducing impurities into the thermoelectric materials 90 and 92 to change their electrical properties. For example, the thermoelectric material 90 may be doped by introducing an impurity with a surplus of electrons to generate an N-type thermoelectric material. Similarly, the thermoelectric material 92 may be doped by introducing an impurity with a surplus of free charge carriers (holes) to generate a P-type thermoelectric material.
The thermoelectric materials 90 and 92 are electrically coupled in series and thermally coupled in parallel. Further, the thermoelectric materials 90 and 92 are alternately arranged between the conductive layers 86 and 88. Accordingly, when current is applied to the conductive layers 86 and 88, heat may be transferred from one side of temperature control element 38A to the other side of temperature control element 38A. In particular, heat may be transferred from one substrate 82 or 84, to the other substrate 84 or 82.
According to certain embodiments, temperature control element 38A includes a bipolar controller with switches that allow the direction of current flow through temperature control element 38A to be reversed. Accordingly, current may be directed through temperature control element 38A in a first direction to provide cooling where heat is transferred from substrate 82 to substrate 84 to cool the emitter 34 and light sources 44 and 46. Further, current may be directed through temperature control element 38A in an opposite direction to provide heating where heat is transferred from substrate 84 to substrate 82 to heat the emitter 34 and light sources 44 and 46. In other words, the direction of current flow determines which substrate 82 or 84 of temperature control element 38A is the hot end and which end is the cool end. Further, according to certain embodiments, the amount of current applied to the temperature control element 38A determines the amount of cooling and heating that is provided. Accordingly, to adjust the level of heating and cooling, the processor 50 (
According to certain embodiments, the processor 50 may transmit control signals to the temperature control element 38A to control the direction of current flow through temperature control element 38A, and to thereby determine whether the temperature control element 38A provides heating or cooling. In the cooling mode, heat from the emitter 34 may be transferred to substrate 82 to cool light sources 44 and 46. The heat from substrate 82 may then be transferred through the thermoelectric materials 90 and 92 to the substrate 84. The heat that is transferred to substrate 84 may be released to the ambient air surrounding the sensor 12. In the heating mode, heat may be transferred from the ambient air to the substrate 84. The heat from the substrate 84 may then be transferred through the thermoelectric materials 90 and 92 to the substrate 82 where the heat may be provided to the emitter 34 to increase the temperature of the light sources 44 and 46.
Regardless of the target temperature, the method 100 may be employed to maintain the temperature of the light sources 44 and 46 at the target temperature even during ambient temperature changes and/or operational temperature changes. For example, if the sensor 12 loses full contact with a patient's finger 78, a low signal to noise ratio may result, and the light sources 74 and 76 may be driven harder. The increased driving strength may increase the temperature of the emitter 34, and accordingly, additional cooling may be desired to cool the light sources 44 and 46, as well as the patient's skin. In another example, when the light drive 64 is operating at a low pulse width modulation (PWM), the temperature produced by the emitter 34 may decrease relative to higher PWM's. In this situation, the temperature control element 38 may be employed to provide heating to maintain the emitter 34 at the desired temperature, and thereby ensure that the light sources 44 and 46 emit the desired wavelengths. In summary, the method 100 may be employed to maintain the light sources 44 and 46 at the target temperature, which in turn, ensures that the desired wavelengths are emitted by the light sources 44 and 46.
The method 100 may begin by determining (block 102) the target temperature. The target temperature may be retrieved from the ROM 56 or from the nonvolatile storage 60 and may correspond to the temperature that the light sources 44 and 46 should be maintained at in order to emit the desired wavelengths. According to certain embodiments, the processor 50 may execute encoded instructions to determine the target temperature that allows the light sources 44 and 46 to emit the desired wavelengths. For example, as discussed further below with respect to
The processor 50 may then receive (block 104) the detected temperature of the light sources 44 and 46. For example, the temperature sensor 40 may detect the temperature of the light sources 44 and 46 and provide data representing the detected temperature to the processor 50. The processor 50 may then determine (block 106) a temperature adjustment based on the detected temperature and the target temperature. For example, the processor 50 may compare the detected temperature to the target temperature and determine the amount and direction of temperature adjustment that is needed to align the temperature of the light source 44 and/or 46 with the target temperature. According to certain embodiments, the processor 50 may employ one or more algorithms or lookup tables to determine the direction and amount of the temperature adjustment.
The processor 50 may then adjust (block 108) operation of the temperature control element to achieve the determined temperature adjustment. For example, the processor 50 may adjust a level of power provided to the temperature control element 38 to increase or decrease the level of heating or cooling provided by the temperature control element 38. According to certain embodiments, the processor 50 may transmit control signals to the power source 76 or to the temperature control element 38 over the bus 54 to adjust the level of power provided to the temperature control element 38. Further, in embodiments where the temperature control element 38 is capable of providing both heating and cooling, the processor 50 may switch the temperature control element 38 between a heating and a cooling mode. For example, as shown in
After the operation of the temperature control element has been adjusted (block 108), the processor 50 may again receive (block 104) the detected temperature and determine (block 106) a temperature adjustment. According to certain embodiments, the method 100 may be repeated continuously or at set intervals to maintain the temperature of the light sources 44 and 46 at the target temperature. Further, as may be appreciated, a certain amount of hysteresis may be employed when adjusting operation of the temperature control element 38. For example, in certain embodiments, the processor 50 may adjust operation of the temperature control element 38 after detecting a threshold amount of change in the temperature of the light sources 44 and 46.
The method 110 may begin by determining (block 112) the wavelengths for the light sources included in the emitter. For example, data indicative of the wavelengths of the light sources 44 and 46 may be stored within the encoder 42, The data from the encoder 42 may then be provided to the decoder 52 in the monitor 14 and may be stored within the ROM 56 or the nonvolatile storage 60. The processor 50 may the retrieve this data from the ROM 56 or the non-volatile storage 60.
The method 100 may then continue by determining (block 114) the calibration wavelengths. For example, a calibration profile including one or more calibration curves and/or algorithms for calculating physiological parameters may be stored within the ROM 56 or the nonvolatile storage 60. The calibration profile may be designed to perform calculations using light sources 44 and 46 that operate at specific wavelengths. These specific wavelengths may be stored within the ROM 56 or the non-volatile storage 60. The processor 50 may then retrieve these wavelengths from the ROM 56 or the nonvolatile storage 60.
The processor 50 may then determine (block 116) a temperature for the light sources 44 and 46 that allows the light sources 44 and 46 to emit light at wavelengths corresponding to the calibration wavelengths. For example, if the peak wavelengths of the light sources 44 and 46 are greater than the calibration wavelengths, a temperature that is higher than the suggested operating temperature for the light sources 44 and 46 may be selected to decrease the wavelengths emitted by the light sources 44 and 46. Similarly, if the peak wavelengths of the light sources 44 and 46 are lower than the calibration wavelengths, a temperature that is lower than the suggested operating temperature for the light sources 44 and 46 may be selected to increase the wavelengths emitted by the light sources 44 and 46. By comparing the light source peak wavelengths to the calibration wavelengths, the processor 50 may determine whether the temperature of the light sources 44 and 46 should be increased or decreased to match the emitted wavelengths to the calibration wavelengths. The processor 50 also may determine the amount by which the temperature should be increased or decreased. For example, the processor 50 may employ one or more algorithms or lookup tables stored in the ROM 56 or the nonvolatile storage 60 to determine the target temperature for the light sources 44 and 46. After determining the target temperature, the processor 50 may then set (block 118) the target temperature for the light sources 44 and 46. For example, the processor 50 may store the target temperature within the ROM 56 or the nonvolatile storage 60. The stored target temperature may then be employed in the method 100 (
Further, in other embodiments, the temperature of the light sources 44 and 46 may be adjusted to emit wavelengths used to determine other physiological parameters such as oxyhemoglobin, carboxyhemoglobin, and methemoglobin, among others. Moreover, in certain embodiments, the method 119 may be employed to vary the wavelength emitted by a light source 44 or 46 based on a current physiological parameter, such as arterial oxygen saturation.
In certain embodiments, the method 119 may be employed to adjust a light source 44 or 46 to emit light at an isosbestic point, where the detected waveform is sensitive to blood volume changes but not to changes in arterial or venous oxygen saturation. For example, the method 119 may be employed to set the wavelength emitted by a light source 44 or 46 to approximately 808 nm, which is an isosbestic point for oxyhemoglobin and de-oxygenated hemoglobin. In other embodiments, the method 119 may be employed to set the emitted wavelength to other isosbestic points, such as an isosbestic point where the absorbance of water and oxyhemoglobin is approximately equal or an isosbestic point where the absorbance of water and de-oxygenated hemoglobin is approximately equal. According to certain embodiments, the method 119 may be employed to adjust a light source 44 or 46 to emit light at a wavelength corresponding to an isosbestic point, and then the method 100 (
As shown in
In certain embodiments, the processor 50 may determine (block 122) a desired adjusted wavelength based on a previously measured physical parameter, such as the level of arterial oxygen saturation. When the arterial oxygen saturation in blood perfused tissue is relatively high (e.g., approximately greater than 84%), the SpO2 value may be more accurately calculated using infrared light paired with light of a relatively low wavelength (approximately 620-700 nm). On the other hand, when the arterial oxygen saturation in blood perfused tissue is relatively low (e.g., less than 75%), the SpO2 value may be more accurately calculated using infrared light paired with light of a relatively higher wavelength (approximately 690-770 nm). Accordingly, it may be desirable to increase the emitted wavelength when the arterial oxygen saturation decreases and to decrease the emitted wavelength when the arterial oxygen saturation increases. One or more previously measured arterial oxygen saturation values may be used to calculate a desired adjusted wavelength. For example, the processor 50 may calculate a desired adjusted wavelength based on an average of previously measured arterial oxygen saturation values, based on a trend in previously measured arterial oxygen saturation values, or based on the most recently measured arterial oxygen saturation value. According to certain embodiments, the processor 50 may employ one or more algorithms and/or lookup tables stored in the ROM 56 or the nonvolatile storage 60 to determine the adjusted wavelength that corresponds to the previously measured arterial oxygen saturation values. According to certain embodiments, the method 119 may be employed to adjust the wavelength emitted by the red light source 44 shown in
After determining (block 122) the desired adjusted wavelength, the processor 50 may determine (block 124) the target temperature for producing the desired wavelength. For example, the processor 50 may compare the desired wavelength to the peak wavelength of the light source 44 or 46 and may then determine whether the temperature should be increased or decreased to produce the desired wavelength. The processor 50 also may determine the amount of temperature adjustment that should be employed to produce the adjusted wavelength. The processor 50 may then set (block 126) the target temperature. For example, the processor 50 may store the target temperature within the ROM 56 or the nonvolatile storage 60.
The target temperature may then be used to measure the desired physiological parameter. For example, the method 100 (
Moreover, in other embodiments, the controller 128 may be replaced by a processor that governs one or more operations of the sensor 12. In these embodiments, the processor may be used to heat the emitter 34 in order to vary the wavelengths of the light sources. For example, the clock speed may be increased or a voltage regulator setting may be adjusted to provide heat for the emitter 34. The processor may operate in conjunction with the temperature control element 38 to provide heating for the emitter 34. For example, in certain embodiments, the temperature control element 38, may be designed to provide only cooling, while the processor provides heating. In another example, the processor may be designed to supplement the heating provided by the temperature control element 38. Further, in certain embodiments, the temperature control element 38 may be omitted and the processor may provide the sole source of heating for the emitter 34.
While the disclosure may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and have been described in detail herein, However, it should be understood that the embodiments provided herein are not intended to be limited to the particular forms disclosed. Indeed, the disclosed embodiments may not only be applied to measurements of blood oxygen saturation, but these techniques may also be utilized for the measurement and/or analysis of other blood constituents. For example, the present techniques may be utilized for the measurement and/or analysis of earboxyhemoglobin, methemoglobin, total hemoglobin, fractional hemoglobin, intravascular dyes, and/or water content. Further, the various embodiments may cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure as defined by the following appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4913150 | Cheung et al. | Apr 1990 | A |
4926867 | Kanda et al. | May 1990 | A |
5007423 | Branstetter et al. | Apr 1991 | A |
5066859 | Karkar et al. | Nov 1991 | A |
5259381 | Cheung et al. | Nov 1993 | A |
5361758 | Hall et al. | Nov 1994 | A |
5427093 | Ogawa et al. | Jun 1995 | A |
5477853 | Farkas et al. | Dec 1995 | A |
5673692 | Schulze et al. | Oct 1997 | A |
6356774 | Bernstein et al. | Mar 2002 | B1 |
6400971 | Finarov et al. | Jun 2002 | B1 |
6512937 | Blank et al. | Jan 2003 | B2 |
6556852 | Schulze et al. | Apr 2003 | B1 |
6850789 | Schweitzer, Jr. et al. | Feb 2005 | B2 |
6902291 | Rizkin et al. | Jun 2005 | B2 |
7496391 | Diab et al. | Feb 2009 | B2 |
7525191 | Nakazato et al. | Apr 2009 | B2 |
7586125 | Dai et al. | Sep 2009 | B2 |
7731377 | Moriya et al. | Jun 2010 | B2 |
7761127 | Al-Ali et al. | Jul 2010 | B2 |
20030109776 | Jacques | Jun 2003 | A1 |
20050283081 | Lin et al. | Dec 2005 | A1 |
20070043278 | Mannheimer et al. | Feb 2007 | A1 |
20070197887 | Lunak et al. | Aug 2007 | A1 |
20080242958 | Al-Ali et al. | Oct 2008 | A1 |
20100022859 | Al-Ali et al. | Jan 2010 | A1 |
20100096993 | Ashdown et al. | Apr 2010 | A1 |
20110190600 | McKenna et al. | Aug 2011 | A1 |
20120071739 | Chen et al. | Mar 2012 | A1 |
Number | Date | Country |
---|---|---|
69123448 | May 1997 | DE |
9316629 | Sep 1993 | WO |
2006109072 | Oct 2006 | WO |
Entry |
---|
Buschman, J.P., et al.; “Principles and Problems of Calibration of Fetal Oximeters,” Biomedizinische Technik, vol. 42, pp. 265-266 (1997). |
Lopez-Silva, S.M., et al.; “Transmittance Photoplethysmography and Pulse Oximetry With Near Infrared Laser Diodes,” IMTC 2004—Instrumentation and Measurement Technology Conference, Como, Italy, May 18-20, 2004; pp. 718-723. |
U.S. Appl. No. 12/751,806, filed Mar. 31, 2010, Mckenna et al. |
Number | Date | Country | |
---|---|---|---|
20120248985 A1 | Oct 2012 | US |